.Following a poor showing for Lykos Therapeutics' MDMA applicant for trauma at a latest FDA advisory...
.AN2 Therapeutics is reviewing its company in feedback to dull midphase information, pledging to giv...
.Merck & Co. is actually paying $700 million upfront to challenge Amgen in a blood stream cancer ...
.With Gilead Sciences almost an FDA selection for its liver disease medication seladelpar, the busin...
.CEO David Ricks may find the companies putting together tents at basecamp behind Eli Lilly in a try...
.Cushion Liquidators has transformed Entero Rehabs white as a sheet. The lender bought Entero to set...
.Exelixis is losing hope on its own cells factor (TF)- targeting antibody-drug conjugate after concl...
.3 full weeks after Roche's Genentech unit left an SHP2 inhibitor treaty, Relay Therapeutics has act...
.Stoke Therapies' Dravet disorder medication has actually been without a partial hold, removing the ...
.Strong Biotech Partner Editor Gabrielle Masson offered the 2024 course of Tough 15 champions on the...